Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements!
Moving stocks this morning are study data, acquisition updates, a secondary stock offering and more.
Let’s get into that news below!
Biggest Pre-Market Stock Movers: 10 Top Gainers
- SMX (Security Matters) (NASDAQ:SMX) stock is rocketing more than 100% alongside heavy pre-market trading.
- Tempest Therapeutics (NASDAQ:TPST) shares are soaring over 50% .
- Reliance Global Group (NASDAQ:RELI) stock is surging close to 35% on .
- Nexalin Technology (NASDAQ:NXL) shares are gaining more than 21% without any clear news this morning.
- Molecular Partners (NASDAQ:MOLN) stock is rising over 17% on Thursday morning.
- Denali Capital (NASDAQ:DECA) shares are increasing more than 17% in .
- Schmid Group (NASDAQ:SHMD) stock is climbing over 16% today.
- Presto Automation (NASDAQ:PRST) shares are heading more than 16% higher this morning.
- Talphera (NASDAQ:TLPH) stock is jumping over 15% without any obvious news to report.
- Aslan Pharmaceuticals (NASDAQ:ASLN) shares are up more than 14% on Thursday.
10 Top Losers
- Avrobio (NASDAQ:AVRO) stock is crashing over 91% on .
- NLS Pharmaceutics (NASDAQ:NLSP) shares are plummeting more than 22% after a recent rally.
- Kaival Brands Innovations (NASDAQ:KAVL) stock is diving over 17% on Thursday.
- 1847 Holdings (NYSEMKT:EFSH) shares are taking a more than 17% beating on a .
- La Rosa (NASDAQ:LRHC) stock is tumbling over 16% after a .
- Huize (NASDAQ:HUIZ) shares are sliding more than 15% on .
- Actelis Networks (NASDAQ:ASNS) stock is falling over 13% after a rally.
- N2OFF (NASDAQ:NITO) shares are decreasing more than 13% .
- Mustang Bio (NASDAQ:MBIO) stock is dropping over 13% following a rally.
- Qualigen Therapeutics (NASDAQ:QLGN) shares close out our pre-market stock movers down 13% today.
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.